Arkolith/Insider Trading/AKBA/Form 4

Dahan Michel

SVP, Chief Operating OfficerAkebia Therapeutics, Inc. (AKBA) · full profile →Form 4 · filed May 14, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$44K
Net Open-Market Flow
-$44K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2024Sell(S)35K$1.26$44K672K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-004025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML